Fjarde Ap-fonden’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319M Buy
1,256,669
+40,700
+3% +$9.49M 1.52% 12
2026
Q1
$297M Buy
1,215,969
+419,769
+53% +$97.8M 1.62% 11
2025
Q4
$165M Sell
796,200
-9,800
-1% -$1.94M 1.38% 12
2025
Q3
$149M Buy
806,000
+7,731
+1% +$1.32M 1.29% 11
2025
Q2
$122M Buy
798,269
+139,300
+21% +$21.4M 1.12% 13
2025
Q1
$109M Sell
658,969
-114,644
-15% -$17.9M 1.31% 11
2024
Q4
$112M Buy
773,613
+5,300
+0.7% +$821K 1.13% 13
2024
Q3
$125M Buy
+768,313
New +$122M 1.27% 10
2024
Q1
$114M Buy
718,313
+14,034
+2% +$2.23M 1.26% 10
2023
Q4
$110M Sell
704,279
-34,229
-5% -$5.25M 1.38% 8
2023
Q3
$115M Sell
738,508
-81,163
-10% -$13.4M 1.53% 8
2023
Q2
$136M Buy
819,671
+34,100
+4% +$5.5M 1.66% 6
2023
Q1
$122M Sell
785,571
-13,800
-2% -$2.23M 1.64% 5
2022
Q4
$141M Sell
799,371
-61,631
-7% -$10.6M 2.01% 3
2022
Q3
$153M Hold
861,002
1.92% 5
2022
Q2
$153M Buy
861,002
+193,800
+29% +$34.5M 1.92% 5
2022
Q1
$118M Sell
667,202
-270
-0% -$45.9K 1.17% 12
2021
Q4
$114M Sell
667,472
-47,200
-7% -$7.73M 1.01% 14
2021
Q3
$115M Sell
714,672
-17,899
-2% -$3.05M 1.06% 12
2021
Q2
$121M Sell
732,571
-36,700
-5% -$6.08M 1.11% 11
2021
Q1
$126M Buy
769,271
+6,300
+0.8% +$1.02M 1.15% 12
2020
Q4
$120M Sell
762,971
-27,100
-3% -$4M 1.14% 10
2020
Q3
$118M Buy
790,071
+29,000
+4% +$4.29M 1.28% 9
2020
Q2
$107M Buy
761,071
+34,042
+5% +$4.96M 1.34% 8
2020
Q1
$95.3M Sell
727,029
-42,207
-5% -$5.99M 1.53% 8
2019
Q4
$112M Sell
769,236
-13,100
-2% -$1.78M 1.38% 9
2019
Q3
$101M Sell
782,336
-4,900
-0.6% -$646K 1.32% 9
2019
Q2
$110M Sell
787,236
-44,700
-5% -$6.19M 1.4% 6
2019
Q1
$116M Buy
831,936
+171,008
+26% +$22.9M 1.46% 6
2018
Q4
$85.3M Sell
660,928
-51,800
-7% -$7.23M 1.47% 5
2018
Q3
$98.5M Sell
712,728
-29,712
-4% -$3.95M 1.45% 7
2018
Q2
$90.1M Sell
742,440
-18,521
-2% -$2.31M 1.36% 9
2018
Q1
$97.5M Buy
760,961
+7,138
+0.9% +$965K 1.49% 6
2017
Q4
$105M Buy
753,823
+113,115
+18% +$15.8M 1.6% 6
2017
Q3
$83.3M Buy
640,708
+13,582
+2% +$1.8M 1.59% 5
2017
Q2
$83M Buy
627,126
+83,615
+15% +$10.7M 1.67% 4
2017
Q1
$67.7M Sell
543,511
-41,840
-7% -$5M 1.62% 4
2016
Q4
$67.4M Sell
585,351
-62,702
-10% -$7.24M 1.58% 3
2016
Q3
$76.6M Buy
648,053
+15,728
+2% +$1.91M 1.68% 5
2016
Q2
$76.7M Buy
632,325
+2,820
+0.4% +$320K 1.78% 4
2016
Q1
$68.1M Buy
629,505
+80,067
+15% +$8.29M 1.58% 5
2015
Q4
$56.4M Buy
549,438
+319
+0.1% +$32.1K 1.48% 5
2015
Q3
$51.3M Sell
549,119
-37,923
-6% -$3.67M 1.43% 4
2015
Q2
$57.2M Sell
587,042
-44,691
-7% -$4.48M 1.38% 6
2015
Q1
$63.6M Sell
631,733
-40,601
-6% -$4.13M 1.46% 5
2014
Q4
$70.3M Sell
672,334
-47,712
-7% -$5.03M 1.52% 5
2014
Q3
$76.8M Sell
720,046
-57,631
-7% -$5.98M 1.64% 5
2014
Q2
$81.4M Sell
777,677
-36,212
-4% -$3.66M 1.62% 5
2014
Q1
$79.9M Buy
813,889
+31,136
+4% +$2.89M 1.59% 5
2013
Q4
$71.7M Sell
782,753
-45,557
-5% -$4.2M 1.5% 6
2013
Q3
$71.8M Sell
828,310
-58,987
-7% -$5.29M 1.55% 5
2013
Q2
$76.2M Buy
+887,297
New +$75.3M 1.58% 5

Other funds holding JNJ

Fjarde Ap-fonden's JNJ Position: Q2 2026 in Review

Fjarde Ap-fonden increased its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, buying an estimated $9.49M and bringing the position to 1,256,669 shares worth $319M. The position accounts for 1.52% of the portfolio, ranked #12.

Fjarde Ap-fonden first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 2,105 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fjarde Ap-fonden held 1,256,669 shares of Johnson & Johnson worth $319M as of Q2 2026.
  • Fjarde Ap-fonden bought 40,700 Johnson & Johnson shares in Q2 2026, an estimated $9.49M.
  • Johnson & Johnson made up 1.52% of Fjarde Ap-fonden's portfolio in Q2 2026, its #12 holding.
  • Fjarde Ap-fonden first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 2,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.